Odonate

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Odonate and buy or sell other stocks, ETFs, and their options commission-free!

About ODTC

Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. 

CEO
Kevin C. Tang
CEOKevin C. Tang
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2013
Founded2013
Employees
Employees

ODTC Key Statistics

Market cap
321.82M
Market cap321.82M
Price-Earnings ratio
-0.83
Price-Earnings ratio-0.83
Dividend yield
Dividend yield
Average volume
1.70
Average volume1.70
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4,840.00
52 Week high$4,840.00
52 Week low
$3,000.00
52 Week low$3,000.00

Stock Snapshot

The current Odonate(ODTC) stock price is $22,005.00, with a market capitalization of 321.82M. The stock trades at a price-to-earnings (P/E) ratio of -0.83.

On 2026-03-04, Odonate(ODTC) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.7.

The stock's 52-week range extends from a low of $3,000.00 to a high of $4,840.00.

The stock's 52-week range extends from a low of $3,000.00 to a high of $4,840.00.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.